BALAXI23.09

BALAXI PHARMACEUTICALS LIMITED

· Unclassified
₹ CrorePeersPARSTEELCITYLATTEYSCROWNHECPROJECTHINDCONAIROLAMGROBTEAMcap ₹127 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
BALAXI
FY26
PAR
FY26
STEELCITY
FY26
LATTEYS
FY26
Peer
Median
Valuation — at last close
P/E88.81×9.56×34.68×22.12× +302%
P/B0.51×1.00×5.18×3.09× -83%
EV/EBITDA19.78×8.61×22.16×15.39× +29%
Market Cap₹127 Cr₹138 Cr₹124 Cr₹131 Cr -3%
Growth
Revenue CAGR 3Y-7.05%2.68%4.48%3.58% -297%
Revenue CAGR 5Y3.15%3.53%3.53% -11%
Net Income CAGR 3Y-68.64%4.97%8.43%6.70% -1124%
Revenue YoY (latest Q)14.05%20.10%28.51%59.21%28.51% -51%
Net Income YoY (latest Q)347.57%41.60%66.71%182.25%66.71% +421%
Profitability
EBITDA Margin3.16%16.53%26.84%5.61%16.53% -81%
Net Income Margin0.52%12.65%22.95%3.04%12.65% -96%
Return on Common Equity0.57%11.71%10.47%14.91%11.71% -95%
Return on Capital Employed2.15%11.63%11.22%21.38%11.63% -82%
Return on Assets0.42%10.15%6.02%4.31%6.02% -93%
Credit & Quality
Total Debt/Equity0.22×0.00×0.07×0.91×0.07× +214%
Interest Coverage1.63×105.48×17.51×4.78×17.51× -91%
Scale — latest FY
Revenue / Total Income₹270 Cr₹104 Cr₹62.3 Cr₹117 Cr₹104 Cr +161%
Net Income₹1.4 Cr₹13.1 Cr₹14.3 Cr₹3.6 Cr₹13.1 Cr -89%
Total Assets₹337 Cr₹129 Cr₹237 Cr₹82.6 Cr₹129 Cr +161%
EPS₹0.26₹10.65₹9.57₹0.62₹9.57 -97%
Book Value per Share₹45.12₹91.01₹91.35₹4.15₹91.01 -50%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.